Related Experiment Video
Updated: Oct 28, 2025

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
Published on: December 23, 2020
AID and APOBECs as Multifaceted Intrinsic Virus-Restricting Factors: Emerging Concepts in the Light of COVID-19
Anastasia Meshcheryakova1, Peter Pietschmann1, Philip Zimmermann2
1Department of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Insights
The activation-induced cytidine deaminase (AID) and apolipoprotein B mRNA editing enzyme catalytic subunit (APOBEC) family are key antiviral systems. Their role in COVID-19, including APOBEC4 expression and AID in antibody production, is explored.
Area of Science:
- Immunology
- Virology
- Genetics
Background:
- The activation-induced cytidine deaminase (AID)/apolipoprotein B mRNA editing enzyme catalytic subunit (APOBEC) family acts as an intrinsic host antiviral system against various viruses, including coronaviruses.
- These enzymes are cytosine-to-uracil deaminases; AID is crucial for humoral immune responses, while APOBECs restrict viral replication through diverse mechanisms.
Purpose of the Study:
- To explore the connection between AID/APOBECs and SARS-CoV-2.
- To investigate the role of APOBEC4 expression in SARS-CoV-2 targeted cells and AID's function in lymphoid structures related to antibody production.
- To propose analyzing AID/APOBECs gene signatures and polymorphisms for understanding patient-specific antiviral responses to COVID-19.
Main Methods:
- Expression analysis of APOBEC4 in cell types and anatomical regions susceptible to SARS-CoV-2.
- Focus on lymphoid structures and AID's role in germinal center reactions and antibody production.
- Proposal for dissecting AID/APOBECs gene signatures and mapping patient-specific polymorphisms.
Main Results:
- Discovery of high APOBEC4 expression in cells and tissues targeted by SARS-CoV-2.
- Highlighting AID's critical role as a master regulator in germinal center reactions, leading to antibody production by B cells.
- Identification of potential patient-specific determinants for antiviral response based on AID/APOBECs.
Conclusions:
- The AID/APOBEC family plays a significant role in the host's antiviral defense against SARS-CoV-2.
- APOBEC4 expression patterns and AID's function in adaptive immunity are relevant to COVID-19 pathogenesis.
- Analyzing AID/APOBEC gene signatures and polymorphisms may offer insights into individual COVID-19 responses and therapeutic strategies.
Abstract:
The AID (activation-induced cytidine deaminase)/APOBEC (apolipoprotein B mRNA editing enzyme catalytic subunit) family with its multifaceted mode of action emerges as potent intrinsic host antiviral system that acts against a variety of DNA and RNA viruses including coronaviruses. All family members are cytosine-to-uracil deaminases that either have a profound role in driving a strong and specific humoral immune response (AID) or restricting the virus itself by a plethora of mechanisms (APOBECs). In this article, we highlight some of the key aspects apparently linking the AID/APOBECs and SARS-CoV-2. Among those is our discovery that APOBEC4 shows high expression in cell types and anatomical parts targeted by SARS-CoV-2. Additional focus is given by us to the lymphoid structures and AID as the master regulator of germinal center reactions, which result in antibody production by plasma and memory B cells. We propose the dissection of the AID/APOBECs gene signature towards decisive determinants of the patient-specific and/or the patient group-specific antiviral response. Finally, the patient-specific mapping of the AID/APOBEC polymorphisms should be considered in the light of COVID-19.
More Related Videos
Related Concept Videos
The Antiviral System of Bacteria and Archaea: CRISPR
Leaky Scanning
Viral Structure
Viruses with RNA Genomes
Retroviruses
Retrovirus Life Cycles

